MDT

85.63

-0.57%↓

A

113.17

+0.6%↑

VEEV

175.84

-1.21%↓

HQY

82.59

+1.93%↑

CSBR

5.59

-1.58%↓

MDT

85.63

-0.57%↓

A

113.17

+0.6%↑

VEEV

175.84

-1.21%↓

HQY

82.59

+1.93%↑

CSBR

5.59

-1.58%↓

MDT

85.63

-0.57%↓

A

113.17

+0.6%↑

VEEV

175.84

-1.21%↓

HQY

82.59

+1.93%↑

CSBR

5.59

-1.58%↓

MDT

85.63

-0.57%↓

A

113.17

+0.6%↑

VEEV

175.84

-1.21%↓

HQY

82.59

+1.93%↑

CSBR

5.59

-1.58%↓

MDT

85.63

-0.57%↓

A

113.17

+0.6%↑

VEEV

175.84

-1.21%↓

HQY

82.59

+1.93%↑

CSBR

5.59

-1.58%↓

Search

Omnicell Inc

Abrir

SetorSaúde

32.51 -2.05

Visão Geral

Variação de preço das ações

24h

Atual

Mín

31.74

Máximo

32.92

Indicadores-chave

By Trading Economics

Rendimento

-7.5M

-2M

Vendas

3.4M

314M

P/E

Médio do Setor

857.75

57.05

Margem de lucro

-0.645

Funcionários

3,580

EBITDA

-9.8M

21M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+77.71% upside

Dividendos

By Dow Jones

Próximos Ganhos

5 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-678M

1.6B

Abertura anterior

34.56

Fecho anterior

32.51

Sentimento de Notícias

By Acuity

50%

50%

169 / 349 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

30 de mar. de 2026, 23:15 UTC

Notícias Principais

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 de mar. de 2026, 22:36 UTC

Notícias Principais

Australian Government Rules Out Boots on the Ground in the Middle East

30 de mar. de 2026, 22:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 de mar. de 2026, 21:00 UTC

Ganhos

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 de mar. de 2026, 20:15 UTC

Notícias Principais

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 de mar. de 2026, 23:40 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 de mar. de 2026, 23:40 UTC

Conversa de Mercado

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 de mar. de 2026, 23:36 UTC

Conversa de Mercado

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 de mar. de 2026, 23:12 UTC

Conversa de Mercado

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 de mar. de 2026, 22:49 UTC

Conversa de Mercado

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 de mar. de 2026, 22:44 UTC

Conversa de Mercado

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 de mar. de 2026, 22:43 UTC

Conversa de Mercado

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 de mar. de 2026, 22:42 UTC

Conversa de Mercado

South32 Should Go for Growth, Says New Bull -- Market Talk

30 de mar. de 2026, 22:18 UTC

Conversa de Mercado

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 de mar. de 2026, 22:05 UTC

Conversa de Mercado

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 de mar. de 2026, 21:58 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 de mar. de 2026, 21:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 de mar. de 2026, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 de mar. de 2026, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 de mar. de 2026, 21:25 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 de mar. de 2026, 21:25 UTC

Conversa de Mercado

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 de mar. de 2026, 21:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

30 de mar. de 2026, 20:09 UTC

Ganhos

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 de mar. de 2026, 20:00 UTC

Notícias Principais

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

77.71% parte superior

Previsão para 12 meses

Média 58.2 USD  77.71%

Máximo 70 USD

Mínimo 49 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

6

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

169 / 349 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat